SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim Bishop who started this subject5/2/2001 7:04:30 PM
From: KGoodson   of 150070
 
NVID Finalizes Agreement for Bangladesh Distribution


CLEARWATER, Fla., May 2, 2001 (BUSINESS WIRE) -- NVID International, Inc. (Pink Sheets:NVID) today announced that a three year Distribution Agreement has been signed between NVID International, Inc. and Eon Animal Health Products Limited / Petrochem Limited of Dhaka, Bangladesh for the distribution of the company's complete line of ionization products.

The ionization equipment lineup includes the company's U.S. Patent No. 6,017,461 RMS ionization system for disinfecting water supplies to hospitals, schools, public buildings, and small municipalities; the IDS 90 and IDS 400 ionization systems for smaller water treatment applications, and the complete line of Superior Aqua Enterprises Sarasota, Florida ionization equipment for agricultural applications replacing traditional fungicides, herbicides and algaecides in a number of niche markets.

David Larson, NVID's President commented, "Bangladesh has a population of 127 million people all living in a country the size of the state of Wisconsin...and they don't have a clear cost-effective strategy to disinfect water. I believe our complete line of ionization technologies that will be distributed by Eon Animal Health Products Limited / Petrochem Limited will be part of the solution."

Separate agreements are being negotiated between NVID and Eon Animal Health Products Limited / Petrochem Limited for specific market applications with NVID's U.S. patented, non-toxic disinfectant Axenohl. Additionally, a proprietary absorbent process for arsenic removal is also being negotiated between the two companies, in which NVID is currently in negotiations with a U.S. based company for certain marketing rights to the proprietary arsenic removal technology.

As previously announced in a March 8, 2001 press release, the U.S. Patent and Trademark Office issued U.S. Patent No. 6,197,814 for the product known as Axenohl. NVID owns the rights to the disinfectant by assignment and is now in the process of considering national and international distributors for distribution of the product.

Axenohl is a revolutionary anti-microbial technology that uses the biocidal properties of ionic silver to kill bacteria and viruses. The disinfection efficacy of Axenohl has been well documented by independent testing laboratories. Axenohl eliminates the following test organism strains all within one minute and 99.9999% efficacy.

Pseudomonas aeruginosa ATCC 15442
Staphylococcus aureus ATCC 6538
Salmonella cholerasuis ATCC 10708
E. Coli ATCC 0157:H7
Listeria monocytogenes ATCC 11543
Enterococcus faecium ATCC 11543
Rhinovirus (common colds)
Rotavirus (infectious diarrhea)
Vancomycin-resistant-enterococci (VRE)

Target markets for NVID's patented ionization disinfection technologies include; hospital and nursing home water systems, point-of-use / point-of-entry; municipal, commercial and residential drinking water systems, FDA compliant consumer products, pools / spas, cisterns / wells, veterinary, horticulture, agriculture and food processing applications.

About NVID International, Inc.

NVID International, Inc. based in Clearwater, Florida manufactures and markets patented ionization disinfection technologies that substantially reduce or replace traditional disinfectants such as quaternary ammonium salts, phenols, and chlorine or bromine based halogens.

The matters discussed in this news release are forward-looking statements with respect to the future activities of the Company. These forward-looking statements by their very nature involve risks and uncertainties and represent the Company's judgement as of the date of this release. NVID International, Inc. and Aqua Bio Technologies, Inc. can be reached at:

Corporate Office: 28163 U.S. 19 N. Suite 302 Clearwater, Florida 33761 Contact: David Larson Phone (727) 669-5005 Fax (727) 669-4701 e-mail dLarson@aquabiotech.com

Sales Office: 5153 Sandy Cove Avenue Sarasota, Florida 34242 Contact: Michael Redden Phone (941) 312-9100 Fax (941) 312-9300 e-mail aquabiotech@home.com

CONTACT: NVID International, Inc., Clearwater
David Larson, 727/669-5005
or
Michael Redden, 941/312-9100

URL: www.businesswire.com
Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.

Copyright (C) 2001 Business Wire. All rights reserved.

-0-

KEYWORD: FLORIDA INTERNATIONAL ASIA PACIFIC
INDUSTRY KEYWORD: ENVIRONMENT
CHEMICALS/PLASTICS

STOCK SYMBOLS: [(nvid)]
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext